P-297CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress. (20th June 2018) - Shah, M; Grothey, A; Tebbutt, N; Xu, R; Yoshino, T; Cervantes, A; Tabernero, J; Taieb, J; Falcone, A; Xu, B; Fontaine, M; Borodyansky, L; et al.